ZME Science on MSN
A new type of immunotherapy drug for prostate cancer shows up to 99% drop in cancer biomarkers
Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments ...
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
The average age of men who get diagnosed is 67.
Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.
Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...
A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.
Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small ...
People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...
The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...
Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results